Gaudium IVF于2026年2月27日在印度证券交易所首次亮相，在零售需求强劲的推动下，价格较IPO价格上涨了5%。 Gaudium IVF debuted on Indian stock exchanges Feb. 27, 2026, rising 5% above its IPO price amid strong retail demand.

Gaudium IVF 与 Women Health 于2026年2月27日在印度证券交易所首次亮相，开盘价为₹83——比其79卢比的首次公开募股价高出5%，此前筹集了1.65亿卢比，且发行量极为高。 Gaudium IVF & Women Health debuted on India’s stock exchanges on February 27, 2026, opening at ₹83—5% above its ₹79 IPO price—after raising ₹165 crore in a highly subscribed offering. IPO于2月24日关闭,在零售和非机构需求强劲的驱动下,超标7.27倍,尽管符合资格的机构兴趣不大。 The IPO, which closed on February 24, saw 7.27 times oversubscription, driven by strong retail and non-institutional demand, though qualified institutional interest was modest. 该公司在全印度经营30个生育诊所,计划将收入用于扩张和偿还债务。 The company, operating 30 fertility clinics across India, plans to use proceeds for expansion and debt repayment. 尽管对灰色市场抱有平坦的预期,但股票升至87.15,增长10.31%。 Despite flat grey market expectations, shares rose to ₹87.15, marking a 10.31% gain. 随着Sensex和Nifty的下跌,更大的市场下跌了。 The broader market declined, with the Sensex and Nifty falling.